CSSPF.US Circassia Group Plc

Healthcare Medical Devices USA Stocks
0.8989 USD
Close of Nov 14, 2026
0.7500 0.8989
Market cap
USD 364M
P/E
44.9x
P/B
4.13x
ROE
10.4%
Dividend yield
2.28%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is CSSPF.US undervalued?

Graham number
Price0.8989
Graham value0.3130
Premium187.2%

CSSPF.US trades 187.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Circassia Group Plc fundamental analysis

No fundamental analysis for Circassia Group Plc yet.

Circassia Group Plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Circassia Group Plc

NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc …

Full company profile